US 10550193
Methods and antibody compositions for tumor treatment
granted A61KA61K2039/505A61P
Quick answer
US patent 10550193 (Methods and antibody compositions for tumor treatment) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K2039/505, A61P, A61P17/00, A61P35/00